NCT01430520View on ClinicalTrials.gov

Analgesic Effect of Escitalopram in Total Knee Arthroplasty (TKA)

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

May 31, 2013

Conditions
Postoperative Pain
Interventions
DRUG

Escitalopram

Tables with Escitalopram (10 mg), 1 tablet a day for 7 days, starting on the day of surgery

DRUG

Placebo

Placebo tablets, 1 tablet a day for 7 days, starting on the day of surgery

Trial Locations (3)

2900

Gentofte Hospital, Gentofte Municipality

7100

Vejle Sygehus, Vejle

7500

Regionshospitalet Holstebro, Holstebro

All Listed Sponsors
collaborator

Lundbeck Foundation

OTHER

lead

Hvidovre University Hospital

OTHER

NCT01430520 - Analgesic Effect of Escitalopram in Total Knee Arthroplasty (TKA) | Biotech Hunter | Biotech Hunter